Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine,Tsinghua University
Beijing, Beijing Municipality, 102218, China
NCT Number: NCT06950710
To better understand the occurrence of hepatic ischemia-reperfusion injury (IRI) in patients with non-alcoholic fatty liver disease (NAFLD) and the role of macrophage polarization in this process, this study will retrospectively collect clinical data from patients who underwent partial hepatectomy at Beijing Tsinghua Changgung Hospital between September 2021 and March 2025. Additionally, clinical information and liver blood samples from patients scheduled for partial hepatectomy from April 2025 onward will be prospectively collected. These samples will include normal liver tissue from the resected portion, as well as 5 mL of venous blood obtained before and after surgery. The investigators will compare the severity of hepatic IRI, the expression of macrophage polarization-related proteins, and macrophage polarization markers in blood samples between NAFLD patients and controls. The study aims to determine whether NAFLD patients experience more severe hepatic IRI and to elucidate the role and mechanisms of macrophage polarization in this context. The findings will provide a theoretical basis for understanding the molecular mechanisms underlying hepatic IRI in NAFLD patients, thereby identifying potential therapeutic targets to prevent IRI and improve prognosis in NAFLD patients undergoing partial hepatectomy.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 102218, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study is an observational one with no intervention
Other names: Control
Time frame: 7 days after the operation
ALT、AST
Zhifeng Gao
Other
Mechanisms of Macrophage Polarization in Hepatic Ischemia-Reperfusion Injury in Patients With Non-Alcoholic Fatty Liver Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01499979
Cardiovascular Diseases, Hepatic Ischemia-reperfusion Injury
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT07335198
Digestive System Diseases, Fatty Liver
Auckland, New Zealand
View Trial DetailsNCT06005012
Digestive System Diseases, Fatty Liver
La Jolla, California, United States
View Trial DetailsNCT05583344
Digestive System Diseases, Fatty Liver
Homewood, Alabama, United States
View Trial Details